Effects of Dibutyryl Cyclic-AMP on Neural Stem Cell Survival and Differentiation
Author Information
Author(s): Kim Howard, Zahir Tasneem, Tator Charles H., Shoichet Molly S.
Primary Institution: University of Toronto
Hypothesis
Does dibutyryl cyclic-AMP enhance the survival and differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats?
Conclusion
Dibutyryl cyclic-AMP pre-treatment significantly improves the survival and neuronal differentiation of transplanted neural stem/progenitor cells in spinal cord injury models.
Supporting Evidence
- NSPC survival was highest in the dbcAMP pre-treated group, having approximately 80% survival at both time points.
- Dibutyryl cyclic-AMP pre-treatment resulted in the greatest number of in vivo NSPCs differentiated into neurons (37±4%).
- Untreated NSPCs showed only 15±7% differentiation into neurons.
Takeaway
Researchers found that a special chemical helped brain cells survive and turn into neurons when they were put into injured spinal cords of rats.
Methodology
The study involved transplanting neural stem/progenitor cells into spinal cord injured rats and assessing their survival and differentiation after treatment with dibutyryl cyclic-AMP.
Potential Biases
Potential bias in the selection of treatment groups and the assessment of outcomes.
Limitations
The study primarily focused on short-term outcomes and did not assess long-term effects beyond six weeks.
Participant Demographics
Adult female Sprague-Dawley rats were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website